ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement

Wan, Xin-Xing; Zhang, Dan-Yi; Khan, Md. Asaduzzaman; Zheng, Sheng-Yuan; Hu, Xi-Min; Zhang, Qi; Yang, Rong-Hua*; Xiong, Kun*海南医学院; 1
Frontiers in Endocrinology2022-3-18DOI: 10.3389/fendo.2022.859638
15被引7阅读
引用收藏
分享

摘要

Type 1 diabetes mellitus (T1DM) is an autoimmune disease that attacks pancreatic beta-cells, leading to the destruction of insulitis-related islet beta-cells. Islet beta-cell transplantation has been proven as a curative measure in T1DM. However, a logarithmic increase in the global population with diabetes, limited donor supply, and the need for lifelong immunosuppression restrict the widespread use of beta-cell transplantation. Numerous therapeutic approaches have been taken to search for substitutes of beta-cells, among which stem cell transplantation is one of the most promising alternatives. Stem cells have demonstrated the potential efficacy to treat T1DM by reconstitution of immunotolerance and preservation of islet beta-cell function in recent research. cGMP-grade stem cell products have been used in human clinical trials, showing that stem cell transplantation has beneficial effects on T1DM, with no obvious adverse reactions. To better achieve remission of T1DM by stem cell transplantation, in this work, we explain the progression of stem cell transplantation such as mesenchymal stem cells (MSCs), human embryonic stem cells (hESCs), and bone marrow hematopoietic stem cells (BM-HSCs) to restore the immunotolerance and preserve the islet beta-cell function of T1DM in recent years. This review article provides evidence of the clinical applications of stem cell therapy in the treatment of T1DM.

学科与关键词

关键词
type 1 diabetes mellitusstem cellbeta-cellimmunotolerancetransplantation
相关
加载中…
  • A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus
    Liu Xuebin; Zheng Pei; Wang Xiaodong; Dai Guanghui; Cheng Hongbin; Zhang Zan; Hua Rongrong; Niu Xinxin; Shi Jing; An Yihua*STEM CELL RESEARCH & THERAPY, 2014, 5: 57.被引 12
  • Therapeutic Effects of Stem Cells for the Treatment of Diabetes Mellitus
    Fei, Z. C.; Pei, R. J.; Du, X.; Pan, B.; Li, C. Q.; Cao, H. J.*INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84: 226-234.
  • Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats
    Wang Hongwu; Qiu Xiaoyan; Ni Ping; Qiu Xuerong; Lin Xiaobo; Wu Weizhao; Xie Lichun; Lin Limin; Min Juan; Lai Xiulan; Chen Yunbin; Ho Guyu; Ma Lian*International Journal of Molecular Medicine, 2014, 33(2): 263-270.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2022-03-18
卷期
第 13 卷
页码
859638
DOI
10.3389/fendo.2022.859638
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81971891, 82172196, 81772134]; Key Laboratory of Emergency and Trauma (Hainan Medical University) of the Ministry of Education [KLET-202108]; Hunan Province Natural Science Foundation of China [2018JJ3804]; College Students' Innovation and Entrepreneurship Project [S20210026020013]

作者

  • W

    Wan, Xin-Xing (第一作者)

  • Z

    Zhang, Dan-Yi

查看全部 8 位作者收起作者
  • K

    Khan, Md. Asaduzzaman

  • Z

    Zheng, Sheng-Yuan

  • H

    Hu, Xi-Min

  • Z

    Zhang, Qi

  • Y

    Yang, Rong-Hua (通讯)

    1

  • X

    Xiong, Kun (通讯)

    hainan med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417